about
Vortex keratopathy in a patient receiving vandetanib for non-small cell lung cancer.Evolution of vision reducing cataract in skin smear positive lepromatous patients: does it have an inflammatory basis?Cloudy corneas as an initial presentation of multiple myeloma.Confocal laser-scanning microscopy allows differentiation between Fabry disease and amiodarone-induced keratopathy.Uncertain diagnosis of fabry disease in patients with neuropathic pain, angiokeratoma or cornea verticillata: consensus on the approach to diagnosis and follow-upBreast cancer medications and vision: effects of treatments for early-stage disease.Amiodarone-induced multiorgan toxicity with ocular findings on confocal microscopy.Ocular toxicity from systemically administered xenobiotics.Ocular manifestations of systemic lupus erythematosus: a clinical review.A systematic review on screening for Fabry disease: prevalence of individuals with genetic variants of unknown significance.Ophthalmic adverse drug reactions to systemic drugs: a systematic review.Cornea verticillata supports a diagnosis of Fabry disease in non-classical phenotypes: results from the Dutch cohort and a systematic review.Corneal Epithelial Microcysts due to High-Dose Cytarabine Administration in a Pediatric Acute Myeloid Leukemia Patient.Systemic associations of corneal deposits: a review and photographic guide.Chloroquine keratopathy of rheumatoid arthritis patients detected by in vivo confocal microscopy.Characteristics of corneal phospholipidosis induced by topical ocular application of chloroquine and amiodarone in rabbitsCrystalline deposition in the cornea and conjunctiva secondary to long-term clofazimine therapy in a leprosy patientCytarabine toxicity of the corneal endothelium.
P2860
Q30473842-062D365B-15BA-4CDA-9A2A-B9CA3C784CE5Q33273831-17A7F9C4-37DE-4F1B-80C5-B7D3736B44DCQ33568616-8D9D2696-B9AE-4D2F-9B00-1E54D1F924F0Q33948079-FA6C10CC-ACDC-4742-9F48-B3F90EE8C9E3Q34560209-26D1B44B-EFB9-4836-A357-49F4E0678C28Q35496778-5A8BFDA5-2DFB-47E6-A3C2-8D052B00C23DQ35544233-DA7FC4F2-DEE9-48C2-98BB-87BD5B3A398CQ35892547-C133026A-987C-4B3F-8D44-36C4E7E658C7Q36398299-5CA08919-A998-452B-A4FF-2A7F6828D235Q38127171-4532C9FB-2AA0-4A2D-80F7-8F218056C66DQ38182049-2DAACF6E-475F-4E93-8388-DA1DF71EB190Q38354004-EBA7BAD1-DC87-4886-8B56-CD461678142FQ38754351-E79E5089-788B-4867-8B56-D7BC85067A6FQ38867444-87D06A57-81D5-4F2E-9DB1-765FDE9FB075Q39637648-DC267D78-4B79-4813-9046-60DF03399600Q41912816-6119EFB3-6608-4A36-B1BC-F5B48F29F0B2Q42787057-527215DC-6F34-4DB1-97F0-18B7BFE74D5AQ45737740-4CB2A50E-A273-423B-924D-CD3E0D2763AD
P2860
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Drug-induced corneal complications.
@ast
Drug-induced corneal complications.
@en
type
label
Drug-induced corneal complications.
@ast
Drug-induced corneal complications.
@en
prefLabel
Drug-induced corneal complications.
@ast
Drug-induced corneal complications.
@en
P1476
Drug-induced corneal complications.
@en
P2093
Anthony J Aldave
David A Hollander
P304
P356
10.1097/01.ICU.0000143688.45232.15
P577
2004-12-01T00:00:00Z